Femme et Homme
- | Pays : -
- | Organes : -
- | Spécialités : -
Extrait
Primary objectives: - For Group A (persitient macular edema): To investigate the change in macular edema measured with standard optical coherence tomography (OCT) and the absolute change in visual acuity following intravitreal administered injections of Bevacizumab (Avastin®) compared with non-treatment control in patients with persistent diabetic macular edema following grid lasercoagulation. - For Group B (persistent neovascularisation):∑ For Group B (persistent neovascularisation): To investigate the change of neovascularisation and vitreous hemorrhage following intravitreal administered injections of Bevacizumab (Avastin®) compared with non-treatment control as assessed by fundus photography and fluorescence angiography and the absolute change in visual acuity.
Critère d'inclusion
- persistent diabetic macular edema or persistent active neovascularisation following lasercoagulation